Skip to main content
. 2021 Mar 2;185(2):315–322. doi: 10.1111/bjd.19810

Table 5.

Adverse drug reaction (ADR) in the placebo and glycopyrronium bromide (GPB) 1% groups

Patients with at least one ADR (%)
Placebo GPB 1%
Drug‐related AEs 13 28
Mild 12 21
Moderate 0 7
Severe 1 0
Anticholinergic AEs 5 20
Dry mouth 4 16
Dry nose 0 2
Mydriasis 0 0
Dry eyes/red eyes 1 1
Blurred vision 0 0
Urinary hesitation 0 0
Urinary retention 0 0
Constipation 0 1
Local skin reactions 7 9

AE, adverse effect.